针对性下一代测序揭示了社区获得性肺炎的独特病原体配置,跨年龄和疾病严重程度
Shu Cui1, Bing Wen1, Ying Wang2
1The First Clinical Medical College of Shanxi Medical University, Taiyuan, People's Republic of China.
根据患者的年龄和疾病严重程度,社区获得性肺炎 (CAP) 病原体概况有很大差异. 老年患者和严重病例的混合感染率较高,需要量身定制的诊断和治疗策略,以获得更好的结果.
科学领域:
- 传染性疾病 传染性疾病
- 微生物学 微生物学
- 基因组学就是基因组学.
背景情况:
- 社区获得性肺炎 (CAP) 构成一个重大的全球健康挑战,其病因谱尚未完全理解.
- 目标下一代测序 (tNGS) 已改善了导致CAP的病原体的识别.
- 了解不同患者人口统计学中的病原体特征对于有效管理至关重要.
研究的目的:
- 通过使用tNGS. 调查CAP患者的病原体特征.
- 分析基于患者年龄组和疾病严重程度的病因谱差异.
- 识别不同的人口和严重程度层中普遍存在的特定病原体.
主要方法:
- 对272名住院CAP患者 (2021-2024) 的病因检测结果的回顾性分析.
- 根据年龄 (例如,18-39岁,≥80岁) 和肺炎严重性指数 (PSI) 评分的患者分层.
- 临床特征,病因谱和感染模式的系统评估.
主要成果:
- 在145名分析患者中,65.52%患有多种感染;老年患者 (≥80岁) 显示出最高的混合感染率 (81.82%).
- 病毒和真菌检测率随着年龄的增长而增加 (例如,爱斯坦-巴尔病毒,白菌);年轻的患者 (18-39岁) 更容易感染非典型的病原体 (例如,Mycoplasma pneumoniae).
- 严重的CAP病例的混合感染率 (76.92%) 比轻度病例 (59.14%) 高,重症病例集中于三重共感染. 特定的病原体,如克莱布西埃拉 spp. 和Acinetobacter baumannii在老年人和严重的群体中更常见.
结论:
- CAP的病因谱在不同年龄组和严重程度上有很大的差异.
- 根据年龄和疾病严重程度量身定制的分层诊断和治疗策略至关重要.
- 优化CAP管理需要个性化的方法来改善预后并减少滥用抗生素.
更多相关视频
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
09:12Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
Published on: January 17, 2014
相关概念视频
Pneumonia II: Pathophysiology
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
